bcx9930
Showing 1 - 4 of 4
Paroxysmal Nocturnal Hemoglobinuria Trial in Budapest, Ampang (BCX9930)
Recruiting
- Paroxysmal Nocturnal Hemoglobinuria
- BCX9930
-
Budapest, Hungary
- +1 more
Feb 14, 2023
Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial in Worldwide (BCX9930, Eculizumab, Ravulizumab)
Active, not recruiting
- Paroxysmal Nocturnal Hemoglobinuria (PNH)
- BCX9930
- +2 more
-
Paris, France
- +6 more
Dec 15, 2022
Paroxysmal Nocturnal Hemoglobinuria, PNH Trial in Austria, South Africa, United Kingdom (BCX9930)
Active, not recruiting
- Paroxysmal Nocturnal Hemoglobinuria
- PNH
- BCX9930
-
Vienna, Austria
- +3 more
Feb 15, 2022
Paroxysmal Nocturnal Hemoglobinuria Trial in Austria, South Africa, United Kingdom (BCX9930, Placebo)
Completed
- Paroxysmal Nocturnal Hemoglobinuria
- BCX9930
- Placebo
-
Vienna, Austria
- +3 more
Feb 15, 2022